<<

. 32
( 51 .)



>>

in glucocorticoid feedback induced by prenatal stress. J. Neurosci., 15, 110“16.
Makino, S., Gold, P. W. and Schulkin, J. (1994). Effects of corticosterone on CRH mRNA and
content in the central nucleus of the amygdala and the parvocellular region of the paraven-
tricular nucleus of the hypothalamus. Brain Research, 640, 105“112.
Matthews, S. G. (1998). Dynamic changes in glucocorticoid and mineralocorticoid receptor
mRNA in the developing guinea pig brain. Brain Res. “ Develop. Brain Res., 107(1), 123“32.
Matthews, S. G. (2000). Antenatal glucocorticoids and programming of the developing CNS.
Pediatr. Res., 47(3), 291“300.
177 Prenatal glucocorticoids and the programming of adult disease


Matthews, S. G. (2002). Early programming of the hypothalamo“pituitary“adrenal axis. Trend.
Endocrinol. Metab., 130, 373“80.
McCormick, C. M., Smythe, J. W., Sharma, S. and Meaney, M. J. (1995). Sex-speci¬c effects of
prenatal stress on hypothalamic“pituitary“adrenal responses to stress and brain glucocorti-
coid receptor density in adult rats. Develop. Brain Res., 84, 55“61.
McCormick, J. A., Lyons, V., Jacobson, M. D. et al. (2000). 5 -heterogeneity of glucocorticoid
receptor messenger RNA is tissue speci¬c: differential regulation of variant transcripts by
early-life events. Mol. Endocrinol., 14(4), 506“17.
McTernan, C. L., Draper, N., Nicholson, H. et al. (2001). Reduced placental 11 beta-hydroxysteroid
dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth
restriction: an analysis of possible mechanisms. J. Clin. Endocrinol. Metab., 86(10), 4979“83.
Meaney, M. J., Aitken, D. H., van Berkel, C., Bhatnagar, S. and Sapolsky, R. M. (1988). Effect of
neonatal handling on age-related impairments associated with the hippocampus. Science, 239,
766“8.
Meaney, M. J., Aitken, D. H., Viau, V., Sharma, S. and Sarrieau, A. (1989). Neonatal handling
alters adrenocortical negative feedback sensitivity and hippocampal type II glucocorticoid
receptor binding in the rat. Neuroendocrinology, 50, 597“604.
Meaney, M. J., Aitken, D. H., Sharma, S. and Viau, V. (1992). Basal ACTH, corticosterone
and corticosterone-binding globulin levels over the diurnal cycle, and hippocampal corticos-
teroid receptors in young and aged, handled and non-handled rats. Neuroendocrinology, 55,
204“13.
Meaney, M. J., Diorio, J., Francis, D. et al. (1996). Early environmental regulation of forebrain
glucocorticoid receptor gene expression: implications for adrenocortical responses to stress.
Develop. Neurosci., 18, 49“72.
Meaney, M. J., Diorio, J., Francis, D. et al. (2000). Postnatal handling increases the expression of
cAMP-inducible transcription factors in the rat hippocampus: the effects of thyroid hor-
mones and serotonin. J. Neurosci., 20(10), 3926“35.
Mercado, A. B., Wilson, R. C., Cheng, K. C., Wei, J. Q. and New, M. I. (1995a). Prenatal treatment
and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase de¬ciency.
J. Clin. Endocrinol. Metab., 80(7), 2014“20.
Mercado, A. B., Wilson, R. C., Cheng, K. C., Wei, J. Q. and New, M. I. (1995b). Prenatal treat-
ment and diagnosis of congential adrenal hyperlasia owing to 21-hydroxylase de¬ciency.
J. Clin. Endocrinol. Metab., 80, 2014“20.
Meyer, J. S. (1983). Early adrenalectomy stimulates subsequent growth and development of the
rat brain. Exp. Neurol., 82, 432“46.
Mitchell, J. B., Rowe, W., Boksa, P. and Meaney, M. J. (1990). Serotonin regulates type II corti-
costeroid receptor binding in hippocampal cell cultures. J. Neurosci., 10(6), 1745“52.
Mitchell, J. B., Betito, K., Rowe, W., Boksa, P. and Meaney, M. J. (1992). Serotonergic regulation
of type II corticosteroid receptor binding in hippocampal cell cultures: evidence for the
importance of serotonin-induced changes in cAMP levels. Neuroscience, 48(3), 631“9.
Molnar, J., Nijland, M. J. M., Howe, D. C. and Nathanielsz, P. W. (2002). Evidence for microvas-
cular dysfunction after prenatal dexamethasone at 0.7, 0.75, and 0.8 gestation in sheep. Am.
J. Physiol. Regul. Integr. Comp. Physiol., 283(3), R561“7.
178 J. R. Seckl et al.


Molnar, J., Howe, D. C., Nijland, M. J. M. and Nathanielsz, P. W. (2003). Prenatal dexamethasone
leads to both endothelial dysfunction and vasodilatory compensation in sheep. J. Physiol.
London, 547(1), 61“6.
Moore, V. M., Miller, A. G., Boulton, T. J. C. et al. (1996). Placental weight, birth measurements,
and blood pressure at age 8 years. Arch. Dis. Child., 74, 538“41.
Moritz, K. M., Johnson, K., Douglas-Denton, R., Wintour, E. M. and Dodic, M. (2002). Maternal
glucocorticoid treatment programs alterations in the renin“angiotensin system of the ovine
fetal kidney. Endocrinology, 143(11), 4455“63.
Moss, T. J., Sloboda, D. M., Gurrin, L. C. et al. (2001). Programming effects in sheep of prenatal
growth restriction and glucocorticoid exposure. Am. J. Physiol. Regul. Integr. Comp. Physiol.,
281(3), R960“70.
Mostyn, A., Keisler, D. H., Webb, R., Stephenson, T. and Symonds, M. E. (2001). The role of lep-
tin in the transition from fetus to neonate. Proc. Nutr. Soc., 60(2), 187“94.
Mostyn, A., Pearce, S., Budge, H. et al. (2003). In¬‚uence of cortisol on adipose tissue develop-
ment in the fetal sheep during late gestation. J. Endocrinol., 176, 23“30.
Muneoka, K., Mikuni, M., Ogawa, T. et al. (1997). Prenatal dexamethasone exposure alters brain
monoamine metabolism and adrenocortical response in rat offspring. Am. J. Physiol., 273(5 Pt
2), R1669“75.
Murphy, V. E., Zakar, T., Smith, R. et al. (2002). Reduced 11beta-hydroxysteroid dehydrogenase
type 2 activity is associated with decreased birth weight centile in pregnancies complicated by
asthma. J. Clin. Endocrinol. Metab., 87(4), 1660“8.
Newnham, J. P. and Moss, T. J. (2001). Antenatal glucocorticoids and growth: single versus mul-
tiple doses in animal and human studies. Semin. Neonatol., 6(4), 285“92.
Newnham, J. P., Evans, S. F., Godfrey, M. et al. (1999). Maternal, but not fetal, administration of
corticosteroids restricts fetal growth. J. Matern. Fetal Med., 8(3), 81“7.
Nyirenda, M. J., Lindsay, R. S., Kenyon, C. J., Burchell, A. and Seckl, J. R. (1998). Glucocorticoid
exposure in late gestation permanently programmes rat hepatic phosphoenolpyruvate
carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult
offspring. J. Clin. Invest., 101, 2174“81.
Nyirenda, M. J., Welberg, L. A. M. and Seckl, J. R. (2001). Programming hyperglycaemia in
the rat through prenatal exposure to glucocorticoids “ fetal effect or maternal in¬‚uence?
J. Endocrinol., 170(3), 653“60.
O™Donnell, D., Larocque, S., Seckl, J. R. and Meaney, M. J. (1994). Postnatal handling alters glu-
cocorticoid, but not mineralocorticoid messenger RNA expression in the hippocampus of
adult rats. Brain Res. “ Mol. Brain Res., 26(1“2), 242“8.
Ong, K. K., Ahmed, M. L., Sherriff, A. et al. (1999). Cord blood leptin is associated with size at
birth and predicts infancy weight gain in humans. ALSPAC Study Team, Avon Longitudinal
Study of Pregnancy and Childhood. J. Clin. Endocrinol. Metab., 84(3), 1145“8.
Ortiz, L. A., Quan, A., Weinberg, A. and Baum, M. (2001). Effect of prenatal dexamethasone on
rat renal development. Kidney Int., 59(5), 1663“9.
Osmond, C., Barker, D. J. P., Winter, P. D., Fall, C. H. D. and Simmonds, S. J. (1993). Early
growth and death from cardiovascular disease in women. Br. Med. J., 307, 1524“7.
Pepin, M. C., Pothier, F. and Barden, N. (1992). Impaired type II glucocorticoid-receptor func-
tion in mice bearing antisense RNA transgene. Nature, 355(6362), 725“8.
179 Prenatal glucocorticoids and the programming of adult disease


Phillips, D. I., Barker, D. J., Fall, C. H. et al. (1998). Elevated plasma cortisol concentrations: a
link between low birth weight and the insulin resistance syndrome? J. Clin. Endocrinol. Metab.,
83(3), 757“60.
Phillips, D. I., Walker, B. R., Reynolds, R. M. et al. (2000). Low birth weight predicts
elevated plasma cortisol concentrations in adults from 3 populations. Hypertension, 35(6),
1301“6.
Reinisch, J. M., Simon, N. G. and Karwo, W. G. et al. (1978). Prenatal exposure to prednisone in
humans and animals retards intra-uterine growth. Science, 202, 436“8.
Reul, J. M. H. M. and de Kloet, E. R. (1985). Two receptor systems for corticosterone in rat brain:
microdissection and differential occupation. Endocrinology, 117, 2505“11.
Reynolds, R. M., Walker, B. R., Syddall, H. E. et al. (2001). Altered control of cortisol secretion in
adult men with low birth weight and cardiovascular risk factors. J. Clin. Endocrinol. Metab.,
86(1), 245“50.
RichEdwards, J. W., Stampfer, M. J., Manson, J. E. et al. (1997). Birth weight and risk of
cardiovascular disease in a cohort of women followed up since 1976. Br. Med. J., 315, 396“400.
Robson, A. C., Leckie, C., Seckl, J. R. and Holmes, M. C. (1998). Expression of 11 -hydroxysteroid
dehydrogenase type 2 in the postnatal and adult rat brain. Mol. Brain Res., 61, 1“10.
Rogerson, F. M., Kayes, K. and White, P. C. (1996). No correlation in human placenta between
activity or mRNA for the K (type 2) isozyme of 11 -hydroxysteroid dehydrogenase
and fetal or placental weight. Tenth International Congress of Endocrinology Abstracts
(P1“231), 193.
Rogerson, F. M., Kayes, K. M. and White, P. C. (1997). Variation in placental type 2 11beta-
hydroxysteroid dehydrogenase activity is not related to birth weight or placental weight. Mol.
Cell. Endocrinol., 128, 103“9.
Rosella, G., Zajac, J. D., Kaczmarczyk, S. J., Andrikopoulos, S. and Proietto, J. (1993). Impaired
suppression of gluconeogenesis induced by overexpression of a noninsulin-responsive phospho-
enolpyruvate carboxykinase gene. Mol. Endocrinol., 7(11), 1456“62.
Saegusa, H., Nakagawa, Y., Liu, Y. J. and Ohzeki, T. (1999). In¬‚uence of placental 11 beta-
hydroxysteroid dehydrogenase (11 beta-HSD) inhibition on glucose metabolism and 11 beta-
HSD regulation in adult offspring of rats. Metab. Clin. Exp., 48(12), 1584“8.
Sapolsky, R. M. (1999). Glucocorticoids, stress, and their adverse neurological effects: relevance
to aging. Exp. Gerontol., 34(6), 721“32.
Schubring, C., Kiess, W., Englaro, P. et al. (1997). Levels of leptin in maternal serum, amniotic
¬‚uid, and arterial and venous cord blood: relation to neonatal and placental weight. J. Clin.
Endocrinol. Metab., 82(5), 1480“3.
Seckl, J. R. (1994). Glucocorticoids and small babies. Quart. J. Med., 87, 259“62.
Seckl, J. R. (1998). Physiologic programming of the fetus. Clin. Perinatol., 25, 939“64.
Seckl, J. R. and Miller, W. L. (1997). How safe is long-term prenatal glucocorticoid treatment?
J. Am. Med. Assoc., 277, 1077“9.
Seckl, J. R. and Walker, B. R. (2001). 11 -hydroxysteroid dehydrogenase type 1: a tissue-speci¬c
ampli¬er of glucocorticoid action. Endocrinology, 142, 1371“6.
Seckl, J. R., Dickson, K. L., Yates, C. and Fink, G. (1991). Distribution of glucocorticoid and min-
eralocorticoid receptor messenger RNA expression in human postmortem hippocampus.
Brain Res., 561, 332“7.
180 J. R. Seckl et al.


Shams, M., Kilby, M. D., Somerset, D. A. et al. (1998). 11beta hydroxysteroid dehydrogenase type
2 in human pregnancy and reduced expression in intrauterine growth retardation. Hum.
Reprod., 13, 799“804.
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G. and Vannier, M. W. (1996).
Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. USA, 93, 3908“13.
Shen, C.-N., Seckl, J., Slack, J. and Tosh, D. (2003). Glucocorticoids suppress beta cell develop-
ment and induce hepatic metaplasia in embryonic pancreas. Biochem. J., 375, 41“50.
Simerly, R. B. (2002). Wired for reproduction: organization and development of sexually dimor-
phic circuits in the mammalian forebrain. Annu. Rev. Neurosci., 25, 507“36.
Slieker, L. J., Sloop, K. W., Surface, P. L. et al. (1996). Regulation of expression of ob mRNA and
protein by glucocorticoids and cAMP. J. Biol. Chem., 271(10), 5301“4.
Sloboda, D. M., Moss, T. J., Gurrin, L. C., Newnham, J. P. and Challis, J. R. (2002a). The effect of
prenatal betamethasone administration on postnatal ovine hypothalamic“pituitary“adrenal
function. J. Endocrinol., 172(1), 71“81.
Sloboda, D. M., Newnham, J. P. and Challis, J. R. G. (2002b). Repeated maternal glucocorticoid
administration and the developing liver in fetal sheep. J. Endocrinol., 175, 535“43.
Slotkin, T. A., Barnes, G. A., McCook, E. C. and Seidler, F. J. (1996a). Programming of brainstem
serotonin transporter development by prenatal glucocorticoids. Brain Res. “ Develop. Brain
Res., 93(1“2), 155“61.
Slotkin, T. A., Barnes, G. A., McCook, E. C. and Seidler, F. J. (1996b). Programming of brainstem
serotonin transporter development by prenatal glucocorticoids. Develop. Brain Res., 93, 155“61.
Smith, J. T. and Waddell, B. J. (2002). Leptin receptor expression in the rat placenta: changes in
Ob-Ra, Ob-Rb, and Ob-Re with gestational age and suppression by glucocorticoids. Biol.
Reprod., 67(4), 1204“10.
Smythe, J. W., Rowe, W. B. and Meaney, M. J. (1994). Neonatal handling alters serotonin (5-HT)
turnover and 5-HT2 receptor binding in selected brain regions: relationship to the handling
effect on glucocorticoid receptor expression. Brain Res. “ Develop. Brain Res., 80(1“2), 183“9.
Stein, M. B., Koverola, C., Hanna, C., Torchia, M. G. and McClarty, B. (1997). Hippocampal vol-
ume in women victimized by childhood sexual abuse. Psychol. Med., 27(4), 951“9.
Stewart, P. M., Corrie, J. E. T., Shackleton, C. H. L. and Edwards, C. R. W. (1988). Syndrome of
apparent mineralocorticoid excess: a defect in the cortisol“cortisone shuttle. J. Clin. Invest.,
82, 340“9.
Stewart, P. M., Murry, B. A. and Mason, J. I. (1994). Type 2 11 -hydroxysteroid dehydrogenase
in human fetal tissues. J. Clin. Endocrinol. Metab., 78, 1529“32.
Stewart, P. M., Rogerson, F. M. and Mason, J. I. (1995). Type 2 11 -hydroxysteroid dehy-
drogenase messenger RNA and activity in human placenta and fetal membranes: its relation-
ship to birth weight and putative role in fetal steroidogenesis. J. Clin. Endocrinol. Metab., 80,
885“90.
Stocker, C., O™Dowd, J., Morton, N. et al. (2004). Modulation of susceptibility to weight gain and
insulin resistance in low birthweight rats by treatment of their mothers with leptin during
pregnancy and lactation. Int. J. Obesity, 28, 129“36.
Sugden, M. C., Langdown, M. L., Munns, M. J. and Holness, M. J. (2001). Maternal glucocorti-
coid treatment modulates placental leptin and leptin receptor expression and materno-fetal
181 Prenatal glucocorticoids and the programming of adult disease


leptin physiology during late pregnancy, and elicits hypertension associated with hyperlepti-
naemia in the early-growth-retarded adult offspring. Eur. J. Endocrinol., 145(4), 529“39.
Sun, K., Yang, K. and Challis, J. R. G. (1997). Differential expression of 11beta-hydroxysteroid
dehydrogenase types 1 and 2 in human placenta and fetal membranes. J. Clin. Endocrinol.
Metab., 82, 300“5.
Tangalakis, K., Lumbers, E. R., Moritz, K. M., Towstoless, M. K. and Wintour, E. M. (1992). Effect
of cortisol on blood pressure and vascular reactivity in the ovine fetus. Exp. Physiol., 77, 709“17.
Thomas, L., Wallace, J. M., Aitken, R. P. et al. (2001). Circulating leptin during ovine pregnancy
in relation to maternal nutrition, body composition and pregnancy outcome. J. Endocrinol.,
169(3), 465“76.
Thomassin, H., Flavin, M., Espinas, M. L. and Grange, T. (2001). Glucocorticoid-induced DNA
demethylation and gene memory during development. EMBO J., 20(8), 1974“83.
Trautman, P. D., Meyer-Bahlburg, H. F., Postelnek, J. and New, M. I. (1995). Effects of early pre-
natal dexamethasone on the cognitive and behavioral development of young children: results
of a pilot study. Psychoneuroendocrinology, 20(4), 439“49.
Tronche, F., Kellendonk, C., Kretz, O. et al. (1999). Disruption of the glucocorticoid receptor
gene in the nervous system results in reduced anxiety. Nat. Genet., 23, 99“103.
Uno, H., Lohmiller, L., Thieme, C. et al. (1990). Brain damage induced by prenatal exposure to
dexamethasone in fetal rhesus macaques. I. hippocampus. Develop. Brain Res., 53, 157“67.
Uno, H., Eisele, S., Sakai, A. et al. (1994). Neurotoxicity of glucocorticoids in the primate brain.
Horm. Behav., 28, 336“48.
Vaessen, N., Heutink, P., Janssen, J. A. et al. (2001). A polymorphism in the gene for IGF-I: func-
tional properties and risk for type 2 diabetes and myocardial infarction. Diabetes, 50(3), 637“42.
Valera, A., Pujol, A., Pelegrin, M. and Bosch, F. (1994). Transgenic mice overexpressing phospho-
enolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc. Natl.
Acad. Sci. USA, 91(19), 9151“4.
Venihaki, M. A., Carrigan, P., Dikkes. et al. (2000). Circadian rise in maternal glucocorticoid pre-
vents pulmonary dysplasia in fetal mice with adrenal insuf¬ciency. Proc. Natl. Acad. Sci. USA,
97, 7336“41.
Voice, M., Seckl, J. R., Edwards, C. R. W. and Chapman, K. E. (1996). 11 -hydroxysteroid dehy-
drogenase type 1 expression in 2S-FAZA hepatoma cells is hormonally-regulated: a model for
the study of hepatic corticosteroid metabolism. Biochem. J., 317, 621“5.
Wal¬sch, A., Hallak, M. and Mazor, M. (2001). Multiple courses of antenatal steroids: risks and
bene¬ts. Obstetr. Gynecol., 98(3), 491“7.
Ward, R. M. (1994). Pharmacologic enhancement of fetal lung maturation. Clin. Perinatol., 21,
523“42.
Weaver, I. C. G., Szyf, M. and Meaney, M. J. (2002). From maternal care to gene expression: DNA
methylation and the maternal programming of stress responses. Endocr. Res., 28(4), 699.
Weinstock, M. (2001). Alterations induced by gestational stress in brain morphology and behav-
iour of the offspring. Prog. Neurobiol., 65, 427“51.
Weinstock, M., Matlina, E., Maor, G. I., Rosen, H. and McEwen, B. S. (1992). Prenatal stress
selectively alters the reactivity of the hypothalamic“pituitary adrenal system in the female rat.
Brain Res., 595, 195“200.
182 J. R. Seckl et al.


Welberg, L. A. M. and Seckl, J. R. (2001). Prenatal stress, glucocorticoids and the programming
of the brain. J. Neuroendocrinol., 13, 113“28.
Welberg, L. A. M., Seckl, J. R. and Holmes, M. C. (2000). Inhibition of 11 -hydroxysteroid dehy-
drogenase, the feto-placental barrier to maternal glucocorticoids, permanently programs
amygdala glucocorticoid receptor mRNA expression and anxiety-like behavior in the off-
spring. Eur. J. Neurosci., 12, 1047“54.
Welberg, L. A. M., Seckl, J. R. and Holmes, M. C. (2001). Prenatal glucocorticoid programming
of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implica-
tions for behaviour. Neuroscience, 104, 71“9.
Weyer, C., Funahashi, T., Tanaka, S. et al. (2001). Hypoadiponectinemia in obesity and type 2
diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol.
Metab., 86(5), 1930“5.
White, P. C., Mune, T. and Agarwal, A. K. (1997). 11beta-hydroxysteroid dehydrogenase and the
syndrome of apparent mineralocorticoid excess. Endocr. Rev., 18, 135“56.
Whitelaw, A. and Thoresen, M. (2000). Antenatal steroids and the developing brain. Arch. Dis.
Child. Fetal Neonatal Edn., 83(2), F154“7.
Whorwood, C. B., Franklyn, J. A., Sheppard, M. C. and Stewart, P. M. (1991). Tissue localization
of 11 -hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor.
J. Steroid Biochem. Mol. Biol., 41, 21“8.
Whorwood, C. B., Firth, K. M., Budge, H. and Symonds, M. E. (2001). Maternal undernutrition
during early to midgestation programs tissue-speci¬c alterations in the expression of the glu-
cocorticoid receptor, 11 beta-hydroxysteroid dehydrogenase isoforms, and type 1 angiotensin
II receptor in neonatal sheep. Endocrinology, 142(7), 2854“64.
Yajnik, C. S., Fall, C. H. D., Vaidya, U. et al. (1995). Fetal growth and glucose and insulin metab-
olism in four-year-old Indian children. Diabetic Med., 12, 330“6.
Yang, K., Matthews, S. G. and Challis, J. R. G. (1995). Developmental and glucocorticoid regula-
tion of pituitary 11beta-hydroxysteroid dehydrogenase 1 gene expression in the ovine fetus

<<

. 32
( 51 .)



>>